Inici › Obesitat › Nova York › Rochester
Assaigs clínics de Obesitat a Rochester, NY
14 estudis de Obesitat busquen participants en centres de Rochester i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
ReclutantFase 2
- Rochester Clinical Research /ID# 282484, Rochester
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
ReclutantFase 2
- Rochester Clinical Research, Rochester
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
ReclutantFase 3
- Rochester Clinical Research, LLC, Rochester
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
ReclutantFase 3
- Rochester Clinical Research, Rochester
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
ReclutantFase 3
- Rochester Clinical Research, LLC, Rochester
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
ReclutantFase 3
- Rochester Clinical Research, LLC, Rochester
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
ReclutantFase 2
- Rochester Clinical Research, LLC, Rochester
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
ReclutantFase 2
- Rochester Clinical Research, LLC, Rochester
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
ReclutantFase 3
- Rochester Clinical Research, Rochester
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
ReclutantFase 3
- Kailera Clinical Site, Rochester
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
ReclutantFase 3
- Rochester Clinical Research, Rochester
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
ReclutantFase 3
- University of Rochester, Rochester
Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry
ReclutantEstudi observacional
- University of Rochester Medical Center, Rochester
Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Eastman Institute for Oral Health, University of Rochester, Rochester
Assaigs de Obesitat en altres ciutats
- Houston, TX43 estudis
- Chicago, IL41 estudis
- New York City, NY40 estudis
- San Antonio, TX40 estudis
- Washington, DC33 estudis
- Orlando, FL31 estudis
- Dallas, TX30 estudis
- Boston, MA28 estudis
- Las Vegas, NV27 estudis
- Miami, FL27 estudis
- Baltimore, MD25 estudis
- Jacksonville, FL25 estudis
Altres estudis a Rochester
- Leucèmia mieloide aguda16 estudis
- Càncer de pulmó15 estudis
- Càncer de mama15 estudis
- Càncer (tots els tipus)14 estudis
- Càncer de pulmó de cèl·lules no petites13 estudis
- Sobrepès13 estudis
- Càncer de pròstata10 estudis
- Mieloma múltiple8 estudis
- Càncer metastàtic8 estudis
- Càncer de pàncrees7 estudis
- Distròfia miotònica7 estudis
- Càncer de bufeta7 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.